- Home
- MTB vs RVMD Comparison
MTB vs RVMD Comparison
Compare MTB & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MTB | RVMD |
|---|---|---|
| Founded | 1856 | 2014 |
| Country | United States | United States |
| Employees | 21866 | 883 |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9B | 30.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MTB | RVMD |
|---|---|---|
| Price | $231.02 | $153.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 19 |
| Target Price | ★ $228.59 | $140.84 |
| AVG Volume (30 Days) | 854.0K | ★ 2.5M |
| Earning Date | 04-15-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.78% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.87 | N/A |
| Revenue Next Year | $3.66 | $533.02 |
| P/E Ratio | $13.63 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $174.76 | $34.00 |
| 52 Week High | $239.00 | $166.50 |
Technical Indicators
Market Signals| Indicator | MTB | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 70.39 | 55.40 |
| Support Level | $211.90 | $93.39 |
| Resistance Level | $233.52 | $166.50 |
| Average True Range (ATR) | 3.84 | 6.30 |
| MACD | 1.69 | -1.41 |
| Stochastic Oscillator | 97.84 | 48.60 |
Price Performance
Historical ComparisonAbout MTB M&T Bank Corporation
M&T Bank is a US regional bank with around $215 billion in assets as of the end of the first quarter of 2026. Headquartered in Buffalo, New York, the bank's footprint is mostly concentrated in New England and the US Mid-Atlantic. M&T Bank boasts a community banking approach, and boasts over 900 branches in 13 states and Washington, D.C. Apart from retail and commercial banking, M&T Bank also has wealth management operations through Wilmington Trust and a partnership with LPL Financial, and a corporate trust business.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.